These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 816655)

  • 21. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin.
    Jordan VC; Koerner S
    J Endocrinol; 1976 Feb; 68(02):305-11. PubMed ID: 815505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
    Robinson SP; Jordan VC
    Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution of 123I-labeled 4-hydroxytamoxifen derivatives in rats with dimethylbenzanthracene-induced mammary carcinomas.
    Kruijer PS; Klok RP; van den Koedijk CD; Blankenstein MA; Voskuil JH; Verzeijlbergen JF; Ensing GJ; Herscheid JD
    Nucl Med Biol; 1997 Nov; 24(8):719-22. PubMed ID: 9428596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
    Labrie F; Kelly PA; Asselin J; Raynaud JP
    Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
    Jordan VC; Allen KE
    Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
    Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
    Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of tamoxifen in laboratory animals.
    Jordan VC; Allen KE; Dix CJ
    Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma.
    Boccardo F; Cerruti G; De Menech R; Valenti G; Zanardi S
    Oncology; 1987; 44(4):248-52. PubMed ID: 3112670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 33. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
    Janssens JP; Billiet G; Bonte J; De Loecker W
    Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative antioestrogen action in experimental breast cancer.
    Jordan VC
    Adv Exp Med Biol; 1981; 138():165-78. PubMed ID: 6805259
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptors in DMBA-induced rat mammary tumors before and after ovariectomy.
    Leclercq G; Heuson-Stiennon JA; Nuyens C; Deboel MC; Heuson JC
    Oncology; 1977; 34(4):168-72. PubMed ID: 411078
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin.
    Asselin J; Kelly PA; Caron MG; Labrie F
    Endocrinology; 1977 Sep; 101(3):666-71. PubMed ID: 196828
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
    Tsai TL; Rutledge S; Katzenellenbogen BS
    Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of estradiol and prolactin on galactosyltransferase and alpha-lactalbumin activities in rat mammary gland and mammary tumor.
    Ip C; Dao TL
    Cancer Res; 1978 Jul; 38(7):2077-83. PubMed ID: 418872
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen-binding in vitro by DMBA-induced rat mammary tumors: its relationship to hormone responsiveness.
    Mobbs BG; Johnson IE
    Eur J Cancer (1965); 1974 Nov; 10(11):757-63. PubMed ID: 4219917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.